AFT Pharmaceuticals Ltd. Financial Overview
AFT Pharmaceuticals Ltd.'s market cap is currently AU$327.36M. The company's EPS TTM is AU$0.026; its P/E ratio is 20.66; and it has a dividend yield of 0.53%. AFT Pharmaceuticals Ltd. is scheduled to report earnings on November 19, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
